Drug Patent Profile
Risedronic acid - AbbVie
At a glance
- Drug Originator Procter & Gamble
- Drug Licenced by Ajinomoto; Almirall S.A.; Eisai Co Ltd; Laboratorios Beta; Sanofi; Takeda; The Alliance for Better Bone Health
- Drug Class Bisphosphonates; Calcium regulators; Osteoporosis therapies; Small molecules
- Mechanism of Action Bone resorption factor inhibitors; HMG-CoA reductase inhibitors
- USA Patent Applicants APIL
- USA Patents 18
- NDAs 2
- International Patents 155
- Patent Applications 6,150

Disclaimer
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.